Related Experiment Video
Updated: Jun 27, 2026

Overexpressing and Purifying a Toxic Nuclease from Escherichia coli
Published on: August 29, 2025
Disparate immunity proteins independently inactivate an antibacterial nuclease toxin
Y Vivian Liu1, Jake Colautti1, Youngchang Kim2
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada; Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
Abstract:
Bacteria secrete a diverse arsenal of protein toxins that inhibit the growth of competing species. To avoid self-intoxication, antibacterial toxins are encoded alongside cognate immunity proteins that typically bind to and occlude a toxin's active site, thus neutralizing its activity. Multiple immunity proteins rarely target the same toxin, reflecting the strong coevolution between toxins and their immunity factors. Here, we identify and characterize an antibacterial toxin in a clinical isolate of Pseudomonas aeruginosa, which we term Tde5, and find that it is inhibited by two structurally distinct immunity proteins, Tdi5a and Tdi5b. Informatic analyses reveal that Tde5 is a member of the ββα-metal DNase superfamily, and accordingly, we find that this enzyme inhibits bacterial growth by nonspecifically degrading DNA. This antibacterial activity is counteracted by either Tdi5a or Tdi5b, suggesting that these two immunity proteins function independently to protect bacteria against Tde5-mediated toxicity. Using biochemical and biophysical approaches, we show that Tdi5a and Tdi5b interact with Tde5 with sub-nanomolar affinities and that a trimeric complex forms between these three proteins, indicating that the two immunity factors bind to the toxin through nonoverlapping interfaces. A 1.73 Å X-ray crystal structure of the Tde5-Tdi5a complex reveals that Tdi5a binds to Tde5 through a large electrostatic interface and occludes the toxin's active site, whereas structural modeling reveals that Tdi5b binds an exosite distal to the toxin's active site. Together, these findings define a previously unrecognized dual-immunity mechanism and expand our understanding of antibacterial toxin-immunity dynamics, informing future studies of interbacterial competition and virulence.
More Related Videos
Related Concept Videos
Bacterial Toxins
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Inhibitors of Bacterial DNA Synthesis
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

